Japan, Feb. 27 -- KOBE UNIV has got intellectual property rights for 'MUSCLE ATROPHY INHIBITORY COMPOSITION.' Other related details are as follows:
Application Number: JP,2021-067896
Category (FI): A61K31/7088,A61K39/395@D,A61K45/00,A61P21/00,A61P43/00,111,C07K16/18,C12Q1/68
Stage: PROBLEM TO BE SOLVED: To provide a muscle atrophy inhibitory composition.SOLUTION: A muscle atrophy inhibitory composition includes a CXCL10 expression inhibitor as an active ingredient. The muscle atrophy inhibitory composition includes, as an active ingredient, preferably a CXCL10 inhibitor, more preferably a CXCL10 neutralizing antibody, or still more preferably a TRPV2 activator. The muscle atrophy is muscle atrophy of skeletal muscle. There is also provid...